Atlas Trials

To Determine the Relationship Between Baseline Reversibility and the Efficacy of Indacaterol

Clinical trial NCT01272362 · COMPLETED

Trial details

NCT number
NCT01272362
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Obstructive Pulmonary Disease (COPD)
Start date
2010-04-01
Primary completion
2012-05-01
Enrollment
625

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.